Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Shares Outstanding (Weighted Average) (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $124200.0 as the latest value for Q3 2023.

  • Quarterly Shares Outstanding (Weighted Average) rose 3194.43% to $124200.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $124200.0 through Sep 2023, up 3194.43% year-over-year, with the annual reading at $1.0 million for FY2022, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $124200.0 in Q3 2023 for Bluejay Diagnostics, up from $3770.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.1 million in Q1 2022 to a low of $3770.0 in Q2 2022.